TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
GlaxoSmithKline AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,073,081
|
928,044
|
881,073 |
Financial expenses |
1,568
|
424
|
298 |
Earnings before taxes |
34,153
|
29,885
|
28,577 |
EBITDA |
34,243
|
32,363
|
31,357 |
Total assets |
343,580
|
353,842
|
375,813 |
Current assets |
336,468
|
352,578
|
371,939 |
Current liabilities |
249,651
|
258,638
|
275,635 |
Equity capital |
93,725
|
92,269
|
93,331 |
- share capital |
50,000
![]() |
50,000
![]() |
50,000 |
Employees (average) |
76
|
70
|
69 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
27.3%
|
26.1%
|
24.8% |
Turnover per employee |
14,119
|
13,258
|
12,769 |
Profit as a percentage of turnover |
3.2%
![]() |
3.2%
![]() |
3.2% |
Return on assets (ROA) |
10.4%
|
8.6%
|
7.7% |
Current ratio |
134.8%
|
136.3%
|
134.9% |
Return on equity (ROE) |
36.4%
|
32.4%
|
30.6% |
Change turnover |
145,037
|
46,971
|
-38,120 |
Change turnover % |
16%
|
5%
|
-4% |
Chg. No. of employees |
6
|
1
|
-4 |
Chg. No. of employees % |
9%
|
1%
|
-5% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.